Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors
Current Oncology · 19.04.2026 · 33 (4) · 230
DOI: 10.3390/curroncol33040230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 19.04.2026. Verfasst von Harsh A Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Geetanjali Medical College and Hospital, Udaipur 313001, India. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Disease Risk Factors. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cardiovascular disease (CVD) is a leading cause of non-cancer death among cancer survivors, attributable to cardiotoxic therapies and cardiovascular risk factors. General population risk prediction tools, including ASCVD (Atherosclerotic cardiovascular disease), Framingham’s Score, and PREVENT (Predicting Risk of Cardiovascular Disease EVENTS), lack cancer-specific variables. We evaluated whether these models, even after statistical optimization, could predict cardiovascular mortality in cancer survivors.
Methods
Using the National Health and Nutrition Examination Survey (NHANES) 2001–2018, linked with National Death Index (NDI) mortality data, we conducted a retrospective analysis of 634 and 429 cancer survivors, respectively, across model-specific cohorts free of baseline cardiovascular disease. Discrimination was assessed for ASCVD, Framingham Score, and PREVENT using standardized thresholds of 7.5% and 20%, as well as Youden-optimized cutoffs. Area under the curve (AUC) comparisons were performed using the DeLong non-parametric method.
Results
Standard thresholds showed suboptimal discrimination across all models (AUCs: ASCVD 0.56, Framingham 0.53, PREVENT 0.64). In contrast, Youden-optimized AUCs (ASCVD: 0.68; PREVENT: 0.71; all p < 0.001, DeLong test). Optimization increased the “low-risk” group’s mortality rate from 2.8% to 4.1% (RR = 1.47), suggesting improved statistical fit came at the cost of overestimating the risk. Optimized thresholds outperformed conventional cutoffs, underscoring the necessity for recalibrated, cohort-specific risk stratification in cancer survivors.
Conclusions
Standard risk scores have inadequate discrimination for cardiovascular mortality prediction in cancer survivors. Threshold recalibration improves statistical metrics but does not resolve the structural failure of these models to account for cardiotoxic exposure. Development of cardio-oncology-specific risk models incorporating oncologic exposures is therefore warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Geetanjali Medical College and Hospital, Udaipur 313001, India.
- Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Internal Medicine, P.S.I. Medical College and Hospital, Chinoutpalli 521286, India.
- Department of Cardiovascular and Thoracic Surgery, Heart and Vascular Institute, West Virginia University, Morgantown, WV 26506, USA.
- Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN 46202, USA.
ORCID-Profile: Harsh A Patel, Saifullah Syed, Pranathi Tella
Zitieren
APA
Patel, H. A., Syed, S., Tella, P., Thyagaturu, H., & Patel, B. (2026). Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors. Current Oncology, 33(4), 230. https://doi.org/10.3390/curroncol33040230
Vancouver
Patel HA, Syed S, Tella P, Thyagaturu H, Patel B. Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors. Current Oncology. 2026;33(4):230. doi:10.3390/curroncol33040230
BibTeX
@article{Patel2026,
author = {Patel, Harsh A and Syed, Saifullah and Tella, Pranathi and Thyagaturu, Harshith and Patel, Brijesh},
title = {Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {4},
pages = {230},
doi = {10.3390/curroncol33040230}
}
EUVIMED